Study the role of systemic endotoxemia as driver of chronic inflammation in arthritis.
PI: Kari Eklund
WP3 leader: Rodolfo Gómez Vaamonde
Funding agency: Unión Europea (Research Executive Agency-European Commission)
Funding (in thousands of euros): 7.000.000 €
Duration (funding period): 4 years (01/01/2023 – 12/31/2026)
Olive-Net: Bioactive compounds from Olea europaea: investigation and application in food, cosmetic and pharmaceutical industry.
PI: Alexios Leandros Skaltsounis.
Funding agency: Unión Europea (Research Executive Agency-European Commission)
Funding (in thousands of euros): 1.732.500 €
Duration (funding period): 4 years (03/01/2017 – 08/31/2022)
Therapy for the Prevention of HO Recurrence (TPHOR) trial (Stage I).
PI: Rodolfo Gómez Bahamonde
Funding agency: conect4children – Collaborative network for European clinical trials for children (IMI initiative)
Funding (in thousands of euros): 2.500€
Duration (funding period): 0/1 year (10/2018 to 01/2019)
Identification of biomarkers and factors involved in joint heterotopic ossification and its relationship with innate immune responses.
IP: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 220.220€
Duration (funding period): 3 years (01/01/2023 – 12/31/2025)
Circulating cell characterization and pharmacological inhibition of abnormal bone growth associated with heterotopic ossification.
IP: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 208.120€
Duration (funding period): 3 years (01/01/2020 – 12/31/2022)
Integrated biobank unit, 3D biomodels and animal models at IDIS: a complete translational research.
IP: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 232.650 €
Duration (funding period): 3 years (01/01/2021 – 12/31/2023)
Study of transcription factors associated with changes in DNA methylation during osteoblastogenesis and their role in osteoblast differentiation.
PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 110.715€
Duration (funding period): 3 years (01/01/2017 – 12/31/2019).
Role of LCN2 in osteoarthritis-subchondral bone alterations and new pharmacological approaches to block its induction and other innate immune responses in joint tissues.
PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros): 121.500€
Duration (funding period): 3 years (01/01/2016 to 12/31/2018)
Development a first-class therapy for the treatment of osteoarthritis based on microARN inhibitor oligonucleotides (CPP2021-008792)
PI: Arthex Biothech, S.L.
Funding agency: Ministerio de Ciencia e Innovacción
Funding (in thousands of euros): 987.445 €
Duration (funding period): 4 years (05/02/2022 -05/02/2025)
Generation of functional surfaces for externalized endomedullar implants
PI: Rodolfo Gómez Bahamonde
Funding agency: Instituto de Salud Carlos III
Funding (in thousands of euros)): 121.500€
Duration (funding period): 3 years (10/2020 – 10/2023)
Search for soluble factors involved in heterotopic ossification associated with trauma.
PI: Rodolfo Gómez Bahamonde
Funding agency: Fundación Mutua Madrileña
Funding (in thousands of euros): 120.000€
Duration (funding period): 3 years (07/01/2018 to 07/01/2021)
Growth potential groups (GPC). Xunta de Galicia.
PI: Rodolfo Gómez Vaamonde
Agencia financiadora: Xunt de Galicia
Financiación (en miles de euros): 90.000 €.
Duration (financing period): 3 years (09/01/2022 – 12/31/2024)
3D models for training in ultrasound-guided puncture techniques.
PI: Ana Lois Iglesias
Funding agency: Colegio de Medicos de Coruña
Funding (in thousands of euros): 1.980€
Duration (funding period): 1 year.
3D printed model for traumatology research and training.
PI: Alberto Jorge Mora
Funding agency: Colegio de Medicos de Coruña
Funding (in thousands of euros): 2.100 €
Duration (funding period): 1 year.
New therapy for heterotopic ossification-A4VAL.
PI: Rodolfo Gómez Bahamonde
Funding agency: Agencia pública gallega para la Gestion del Conocimiento (ACIS)
Funding (in thousands of euros): 20.000€
Duration (funding period): 1 year (09/02/2019 – 12/15/2019)
New therapy for heterotopic ossification-I4TRANSF
PI: Rodolfo Gómez Bahamonde
Funding Agency: Galician Public Agency for Knowledge Management (ACIS)
Funding (in thousands of euros): 5.000€
Duration (funding period): 0/1year (09/02/2019 – 12/15/2019)
STOP ARTHROSIS: blocking the origin of inflammation.
PI: Rodolfo Gómez Bahamonde
Agencia financiadora: Fundación Española para la Ciencia y la tecnología-(FECYT)/ Precipita
Financiación (en miles de euros): 5.730 €.
Duration (financing period): 1 year (10/30/2018 – 10/30/2019)
3D printed computerized model for traumatology research and training.
Funding agency: AOTRAUMA Spain
Funding (in thousands of euros): 7.500 CHF
Duration (financing period): 1 year (2019) Year 2019
Proceedings contract/project: SPI 000371
Search for new drugs to block TLR4-associated inflammation in human arthritis chondrocytes.
PI: Ana Lois Iglesias
Funding agency: Spanish Foundation of Rheumatology (SER)
Funding (in thousands of euros): 22.000 €
Duration (funding period): 2019 to 2021 Started Feb 2019
Modifications of titanium surface with a nanometric structure and sintered with calcium ions.
PI: Rodolfo Gómez Bahamonde
Financing agency: Private company Medcom Tech SA .
Financing (in thousands of euros): 4.000€
Duration funding period: 0/1 year (03/08/2018 – 07/08/2018)